Bernstein on BeOne Medicines (ONC): 'A Good Opportunity to Buy Now' Feb 27, 2026 07:07AM
BeOne Medicines (ONC) PT Raised to $362 at Bernstein Oct 9, 2025 08:21AM
BeiGene Ltd. (ONC) PT Raised to $259 at Bernstein After 'Asset and Market Model Updates' Mar 13, 2025 10:42AM
Oncolytics Biotech (ONCY) and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at SITC Nov 9, 2020 08:11AM
Oncolytics Biotech® Inc.'s REOLYSIN® More than Doubles Overall Survival in Patients with Mutated p53 Metastatic Breast Cancer Apr 5, 2017 07:00AM


Mar 31, 2017 04:23PM Oncolytics Biotech® Inc.'s REOLYSIN® Provides Statistically Significant Improvement in Overall Survival in Canadian Cancer Trials Group Sponsored Randomized Phase 2 Study in Metastatic Breast C
Mar 2, 2017 06:30AM Oncolytics Biotech® Inc. Announces Canadian Cancer Trials Group to Present Final Randomized Data from Phase 2 Metastatic Breast Cancer Study at AACR 2017 Annual Meeting